The Longevity Podcast: Optimizing HealthSpan & MindSpan
Welcome to a new era of conversation—where artificial intelligence explores what it means to live longer and better. Created and guided by Dr. Trinh, The Longevity Podcast uses AI hosts to bring scientific discovery, health innovation, and human wisdom together. Through AI-driven discussions inspired by real research and medical insight, each episode reveals practical tools for optimizing your healthspan and mindspan—rooted in science, shaped by compassion.
Mind. Body. Spirit.
Powered by Science, Guided by Humanity.
The Longevity Podcast: Optimizing HealthSpan & MindSpan
How DNA Methylation Builds Epigenetic Clocks
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
We follow the trail from DNA methylation to epigenetic clocks that can read biological age like a personalized receipt of your life. Then we hit the hard limits of today’s tests, especially the gap between predicting lifespan and predicting whether your brain stays sharp.
• DNA methylation as gene control through steric hindrance and chromatin tightening
• Epigenetic clocks built from predictable CpG changes over time
• Why first-generation clocks track birthdays more than health
• PhenoAge and GrimAge as decay predictors tied to inflammation and smoking damage
• French centenarian data showing biological ages decades younger
• Epigenetic drift versus clock-like methylation changes and what superagers reveal
• ELOVL2 and mouse evidence that some aging is reversible gene silencing
• WIMS findings showing blood clocks predict survival not dementia risk
• APOE E2 E3 E4 risk differences and epigenetic “volume dial” control
• FOXO3 activation through fasting via IGF-1 and AKT signaling
• Metformin and rapamycin as fasting mimetics plus the mouse-to-primate reality check
Keep your biological software updated, embrace a little bit of hunger, stay curious, and we'll see you next time.
This podcast is created by Ai for educational and entertainment purposes only and does not constitute professional medical or health advice. Please talk to your healthcare team for medical advice.
Never miss an episode—subscribe on your favorite podcast app!
Biological Time Travel Hook
SPEAKER_01So what if I told you that uh there's a 105-year-old French woman sitting in a cafe right now sipping espresso and she has the exact identical cellular machinery of a 75-year-old. Like biologically, she has somehow just lived 30 years completely off the grid.
SPEAKER_00Well, I I would push back slightly on that phrase, the whole off the grid thing, because the entire point of the data we're looking at today is that your cells are actually always keeping a grid. Like they're keeping a frighteningly accurate, totally individualized receipt of absolutely everything you do. But I mean, your premise is essentially correct. The chronological clock on the wall and the biological clock inside her cells are running at completely different speeds.
SPEAKER_01Aaron Powell Dude, it is wild. Because today's deep dive is into the fascinating and honestly sort of terrifying science of measuring and manipulating biological aging. We are not just talking about, you know, getting wrinkles or gray hair here. We are talking about literal biological time travel.
SPEAKER_00Aaron Powell Yes. And we have a massive stack of sources for this cutting-edge research covering things like epigenetic clock, centenary and DNA, uh this huge project called the WIMS Study on Brain Aging.
SPEAKER_01Oh man, that one messed me up.
SPEAKER_00It's sobering. And we'll get into the exact molecular switches inside you right now, like APOE and FOC XO3 that dictate how long you live, and more importantly, how well you live.
SPEAKER_01Aaron Ross Powell Exactly. And that is uh that's our mission for you today. We want to figure out why some people are biologically decades younger than what their birth certificates say. We're gonna unpack how lifestyle changes actually like physically rewrite your DNA's destiny. So I want you to think about your own biological age right now as you're listening. Right. Think about the number of candles on your last birthday cake, and then ask yourself what's actually happening under the hood.
SPEAKER_00Aaron Powell Because before we can even begin to talk about stopping aging or uh hacking the aging process, as people like to say, we really have to understand how the body physically measures it.
DNA Methylation And Gene Silencing
SPEAKER_00We have to talk about the epigenome.
SPEAKER_01Aaron Powell Right. And I think most people, you know, anyone who follows health science understands the basic concept of DNA, right? It's the blueprint, it's the hardware of your computer, you're born with it, it basically doesn't change. Correct. But the epigenome is like the software. So walk us through the actual physical mechanism here. What is this epigenetic software actually made of?
SPEAKER_00Right. So at the molecular core of all this is a process called DNA methylation. And chemically, it is beautifully simple. It's just the addition of a tiny molecule called a methyl group.
SPEAKER_01Which is what, exactly?
SPEAKER_00That is just one carbon atom bonded to three hydrogen atoms. So CH3. Your body basically takes this tiny methyl group and attaches it directly onto the DNA strand, specifically at places where a cytosine base sits right next to a guanine base. We call these spots CPG dinucleotides.
SPEAKER_01Wait, wait, so when we talk about genes turning on or off, the CH3 thing is the actual physical switch. How does slapping a carbon and three hydrogens onto the DNA actually stop a gene from working? Like, does it just get in the way?
SPEAKER_00That is exactly what it does. It's a concept called steric hindrance. Imagine your DNA as a massive, tightly coiled ball of string. That's chromatin.
SPEAKER_01Okay, I'm with you.
SPEAKER_00For a gene to be expressed, the cellular machinery, meaning the transcription factors, they have to physically land on the DNA strand and read the code. When you attach these bulky methyl groups to the DNA, they literally take up physical space. They just block the transcription machinery from landing.
SPEAKER_01Oh wow. So it's literally like putting a physical padlock on a door.
SPEAKER_00Precisely. And it actually goes even deeper than that. These methyl groups also attract other proteins that essentially spool the DNA even tighter, winding it up so densely that the gene is completely inaccessible. It's totally silenced. Now, for most of your life, this is highly systematic and necessary. Why? Well, your body uses methylation to ensure an eye cell stays in eye cell and doesn't suddenly start, you know, producing stomach acid.
SPEAKER_01Right, which would be terrible. An eyeball full of acid, no thanks.
SPEAKER_00Highly problematic, yes. But as we age, the pattern of this methylation changes. It shifts. Some areas that are supposed to be active get hypermethylated, meaning they get locked up. Meanwhile, other areas actually lose their methyl groups and get inappropriately turned on.
SPEAKER_01Okay, so this software program is basically slowly getting buggier and buggier over time. But what blew my mind in these sources is that this buggy degradation isn't just
Epigenetic Clocks From Horvath To GrimAge
SPEAKER_01like random chaos. It's so predictable that scientists figured out how to build clocks out of it.
SPEAKER_00Yes. Nearly a decade ago, scientists, notably Steve Horvath, realized that a large number of these CPG sites change their methylation status over time with just astonishing mathematical predictability.
SPEAKER_01Like clockwork.
SPEAKER_00Literally, if you look at enough of these specific sites across the genome, you can calculate a highly accurate age for that tissue. These are epigenetic clocks.
SPEAKER_01Right. The original Horvath clock. But I mean, looking at the literature, that first generation clock was basically just a biological party trick, wasn't it?
SPEAKER_00A party trick is a bit harsh, but I see your point.
SPEAKER_01I mean, it looks at your DNA and says, yep, this person has been alive for 45 years. Which is cool for forensics. Like uh if you find a blood drop at a crime scene, but it doesn't tell you anything about how healthy that 45-year-old actually is.
SPEAKER_00Aaron Powell Exactly. The first generation chronological clocks were trained entirely on chronological age. They were designed to predict time since birth. But the field quickly realized the limitation there. I mean, if you and I are both exactly 40 years old chronologically, we're not hypothetically. If we're both 40, but you smoke a pack a day and sleep three hours a night, and I run marathons and eat a perfectly balanced Mediterranean diet, our biological ages should look completely different.
SPEAKER_01Obviously.
SPEAKER_00But a chronological pluck would just say we're both 40.
SPEAKER_01Right. Which brings us to the second generation, the biological clocks.
SPEAKER_00Correct. Clocks like phenynoage and grimmage. And these were revolutionary because instead of being trained to predict your birthday, they were trained to predict your physiological decay. Phenoage, for instance, wasn't just built on age data. It was trained using 10 specific clinical markers of physiological breakdown, things like white blood cell count, albumin levels, and C reactive protein, which is a major marker of systemic inflammation.
SPEAKER_01So it's looking at the methylation patterns on your DNA and correlating them with the actual physical breakdown of your organs in real time.
SPEAKER_00Yes. It looks for the epigenetic signature of inflammation and organ dysfunction. But then the field went a step further with grimmage.
SPEAKER_01Grimmage, which honestly sounds like a super villain name or like a terrible medieval disease.
SPEAKER_00It is aptly named, honestly, because grimmage is an extraordinarily accurate predictor of mortality. It uses plasma proteins, but crucially it uses a metric called smoking pack years to train its model.
SPEAKER_01Okay, hold on. This part of the research stopped me in my tracks because they train this DNA clock using smoking data. Like how many cigarettes a person has smoked? How does your DNA, how do these little CH3 methyl groups know how many cigarettes you've smoked?
SPEAKER_00Because of the profound systemic impact of the toxins in tobacco smoke. When you inhale those chemicals, they trigger massive cellular stress responses, inflammation, and DNA damage throughout your entire body. Right. Your body responds to this constant assault by aggressively altering its epigenetic software. It methylates and demethylates specific genes to try and manage that damage.
SPEAKER_01And Grimmage just reads that damage pattern.
SPEAKER_00It relies on what we call DNA surrogate biomarkers. The epigenetic signature of smoking is so specific, so deeply etched into your DNA methylation patterns, that Grimmage can look at a blood sample and calculate your smoking history with terrifying precision.
SPEAKER_01Dude.
SPEAKER_00You could sit in your doctor's office and lie, swearing you quit a decade ago, but Grimmage knows your blood will completely snitch on you.
SPEAKER_01That is insane. Life insurance companies must be drooling over this tech. You just can't fake it. Your cells literally keep the receipts.
SPEAKER_00They really do. Yeah. And that is why Grimmage outperforms almost every other metric in predicting all-cause mortality, time to cancer, and cardiovascular disease. It captures the true biological toll of your lifestyle choices, written directly onto your genome.
SPEAKER_01Okay. So if Grimmage and Finimage are basically the grim reapers of predictive biology, you know, reading the decay of our software, it naturally makes you wonder what happens when you test people who just absolutely refuse to decay.
SPEAKER_00You were talking about the long-lived individuals, the extreme superagers.
Superagers And The Limits Of Drift
SPEAKER_01Yes, the time travelers. Because if Grimitz predicts death, what does it show when you test a 105-year-old who is like still taking daily walks and living completely independently? This brings us to that massive French study in our sources. And the data here is, I mean, it completely breaks the standard model of aging.
SPEAKER_00Aaron Powell It is a remarkable cohort. They analyze French centenarians and semi-supercentenarians, we'll call them the CSSC group, ranging from 100 to 107 years of age. Yeah. What's crucial here is the methodology.
SPEAKER_01Okay, break it down.
SPEAKER_00Instead of using a clock like Horvath's that looks at hundreds of CPG sites, they tested these superagers using highly specific epigenetic clocks based on a very small, tightly curated number of CPG sites. We're talking just two to four sites total.
SPEAKER_01Which is fascinating in itself. They zoomed all the way in on just a tiny handful of these molecular padlocks, and what did they find? The numbers just blew me away.
SPEAKER_00The epigenetic clocks calculated their biological age to be between 15 and 28.5 years younger than their actual chronological age.
SPEAKER_01I mean, let that sink in for a second if you're listening to this. You are 105 years old on paper. You were born before commercial radio even existed. But the cellular methylation profile of your body looks like someone in their late 70s. That is biologically cheating deaf.
SPEAKER_00It is a profound deceleration of the aging process. And significantly, they found a similar, though slightly less extreme, effect in the offspring of these centenarians. The non-ingenarian and centenarian offspring, the NCO group, they were biologically 4 to 11.5 years younger than their chronological age.
SPEAKER_01So it's heritable. They literally passed down this incredibly resilient software to their kids. But why? What makes their methylation patterns so impossibly stable? When I was looking through the breakdown of the study, there was this really interesting distinction between the epigenetic clock and epigenetic drift.
SPEAKER_00This is a vital mechanical distinction in longevity science. We've been talking about epigenetic clocks, the predictable systematic ticking. Yeah. Certain genes gain or lose methyl groups at a very steady rate across the entire human population. That is the clock. Right. But epigenetic drift is entirely different. Drift is the random chaotic scattering of methylation over time.
SPEAKER_01Okay, so if the clock is a highly precise metronome keeping the temple of aging, the drift is like the individual members of the orchestra slowly getting out of tune, hitting random notes until the whole symphony just sounds like garbage.
SPEAKER_00That is exceptionally good analogy, actually. Drift is the cumulative effect of stochastic or random environmental factors. Every minor cellular stressor, every minor inflammatory event over a lifetime adds a tiny bit of noise to the epigenome.
SPEAKER_01Give me an example of that.
SPEAKER_00Well, identical twins are born with identical meshillation patterns, but by the time they're 75, their epigenomes have drifted significantly apart purely because they experienced different random environmental exposures, different diets, different stress, different illnesses.
SPEAKER_01Okay, so the orchestra gets out of tune for everyone. But what did the French study show about these 105-year-olds?
SPEAKER_00This is where it gets highly technical, but incredibly revealing. They looked at the dispersion of methylation values, the variance at these specific CPG sites. For some sites, the epigenetic drift was massively accelerated, but only in the extreme superagers.
SPEAKER_01Wait, I want to make sure I understand this. You're saying that normal people, people who die at 80 or 85, they literally don't live long enough to even experience this specific type of epigenetic noise.
SPEAKER_00Exactly. The drift at these specific loci only becomes visible when you push the human physiological system to its absolute extreme limit. But here is the counterpart. For other specific CPG sites, the methylation in these centenarians remain incredibly tight, predictable, and fully functional, even at 105 years old. Wow. Meaning that the core biological software governing their survival is almost completely immune to the chaotic noise of aging.
SPEAKER_01That is wild. And when I was digging into the supplemental data of that French study to see like which genes were staying so perfectly tuned, one specific gene kept coming up that I just got completely obsessed with: ELVL2.
SPEAKER_00Ah, yes. ELVL2. It stands for elongation of very long-chain fatty acids protein 2.
SPEAKER_01Very catchy. Just rolls right off the tongue. But this gene is incredible. It's heavily involved in lipid metabolism, right? Specifically in the retina.
SPEAKER_00Yes. It synthesizes very long-chain polyunsaturated fatty acids, which are absolutely critical for the structural integrity and function of photoreceptor cells in your eyes. Now, as a normal human ages, the CPG island associated with the ELVL2 gene becomes progressively hypermethylated. It accumulates those methyl groups.
SPEAKER_01The padlocks get snapped onto the door.
SPEAKER_00Exactly. The steric hindrance we discussed earlier occurs. The transcription machinery can't access the gene, so its expression is downregulated. The older you get, the less of this vital lipid synthesizing protein you produce, and consequently your retinal function declines.
SPEAKER_01Right, which we just call getting old. You get into your 70s, your vision gets worse, macular degeneration kicks in, it's just wear and tear, right? Like a scratch camera
Turning Back Genes Like ELOVL2
SPEAKER_01lens. But, and this is the part that reframes aging entirely, you look at the mouse studies on this specific gene.
SPEAKER_00The mouse study on ELO VL2 is a watershed moment in epigenetics.
SPEAKER_01Ah.
SPEAKER_00Researchers took older mice whose vision had degraded precisely because their ELO VL2 gene had been epigenetically silenced. But instead of treating the eye physically, they intervened at the molecular level.
SPEAKER_01Okay.
SPEAKER_00They artificially removed the hypermesylation. They essentially picked the padlocks off the gene and restored the youthful expression of ELO VL2.
SPEAKER_01And it cured their blindness. Hold on, let's just sit with that. They didn't replace the eye, they didn't give them new stem cells. The lens of the camera wasn't actually scratched at all. The body just forgot how to turn on the autofocus and they just went into the software and flipped it back on.
SPEAKER_00It perfectly illustrates the difference between structural degradation and epigenetic silencing. For decades, we assumed aging was purely structural, the protein simply broke down beyond repair. But this proves that in many tissues, the cellular hardware is still perfectly intact and capable.
SPEAKER_01It's just waiting for instructions.
SPEAKER_00Exactly. The software is just telling it not to run. If you reset the methylation pattern, the hardware boots up and works exactly as it did in youth.
SPEAKER_01I mean, biological age is a two-way street. You can literally put the car in reverse. That is the most optimistic thing I've ever read.
SPEAKER_00It's incredibly promising for specific tissue types.
SPEAKER_01Okay, I hear the four specific tissue types caveat. You're setting me up for a reality check here. Because having the physical body and the perfectly clear vision of a 70-year-old when you're 105 is a massive win. But what about the brain? Does any of this matter if I have the heart and eyes of a young man, but I don't know who my kids are? Do these epigenetic clocks, the grimmages that predict mortality so well, do they predict if we keep our memories?
Why Blood Clocks Miss Dementia
SPEAKER_00This brings us to the most sobering part of the longevity data, honestly, and it takes us straight into the WIM study. Because if we're asking whether our current biological clocks can predict cognitive decline, the answer is a profound, deeply concerning no.
SPEAKER_01Okay, listeners, strap in for this because this is the cognitive blind spot, and it genuinely gave me an existential crisis. Let's break down WIMS. What exactly is this study?
SPEAKER_00WIM stands for the Women's Health Initiative Memory Study. In the world of gerontology, it is a monumental, incredibly robust piece of research. The methodology is staggering. They took a cohort of over 5,800 women, starting all the way back between 1996 and 1999, and they tracked them meticulously for decades.
SPEAKER_01And they were tracking their cognitive function, right? How did they measure that over such a long time?
SPEAKER_00They used rigorous, standardized cognitive assessments over time. Specifically, they used the modified mini mental state examination, and later the telephone interview for cognitive status, which allowed them to track participants even if they became homebound. Smart. They were aggressively monitoring for the onset of mild cognitive impairment or full-blown dementia. And while they were doing this, they were continually taking blood samples to map the participants' DNA methylation profiles.
SPEAKER_01So they have decades of cognitive data matched perfectly with decades of blood DNA, like the perfect setup.
SPEAKER_00Exactly. And recently, researchers took all that blood DNA methylation data and ran it through 15 different state-of-the-art epigenetic clocks. They use Grimage 2, they use Dunedin pace, which doesn't just guess your age but calculates the actual speedometer of your aging at that exact moment.
SPEAKER_01I've heard of that one. Very cool tech.
SPEAKER_00Very. They even use a clock called DNA, which was specifically designed to measure intrinsic capacity and actually included cognitive test scores in his training data.
SPEAKER_01So they threw the absolute best predictive software humanity has ever created at this massive data set. What was the goal? What were they trying to answer?
SPEAKER_00Two very specific questions. First, can these 15 clocks predict exceptional longevity, which they defined as surviving to age 90? And second, and far more importantly, can they predict cognitively healthy longevity? Meaning, can the clocks tell the difference between someone who survives to 90 with a sharp intact memory versus someone who survives to 90 but suffers from severe dementia?
SPEAKER_01Right. What did they find?
SPEAKER_00The first half of the findings were exactly what you'd expect based on our discussion of Grimmage. The advanced second and third generation clocks, particularly Grimmage 2 and Dundan Pace, were phenomenally accurate at predicting who would physically survive to age 90.
SPEAKER_01So the body holds up.
SPEAKER_00Right. If your blood methylation showed accelerated aging, your statistical odds of reaching 90 plummeted. They predicted physical mortality beautifully. But out of all 15 clocks tested, including the ones designed to look at intrinsic capacity, absolutely none of them could predict if a woman would survive to 90 with intact cognition versus surviving with dementia.
SPEAKER_01Wait, literally zero. Like none of them could see the dementia coming.
SPEAKER_00Zero. The statistical odds ratios for surviving to 90 with an intact memory versus surviving to 90 with dementia were virtually indistinguishable across all the clocks. The clocks are entirely blind to neurocognitive aging.
SPEAKER_01So let me put this in practical terms. I could go get my blood tested tomorrow. My Grimmage comes back and says, Congratulations, your biological age is 20 years younger than your driver's license. Your heart is a machine. You are going to easily live to 100. But that same test has absolutely no idea if my brain is currently rotting inside my skull.
SPEAKER_00That is the terrifying reality. You could have the cardiovascular resilience of an elite athlete ensuring your physical survival to a century, while a completely undetected cascade of neurodegeneration is destroying your hippocampus.
SPEAKER_01Honestly, what is the point? What is the point of longevity science or an immortality pill if it just traps a fading mind inside a healthy body? Why are these blood clocks so incredibly blind to the brain?
SPEAKER_00It comes down to the fundamental architecture of the human nervous system, specifically the blood-brain barrier. The epigenetic clocks we currently use are trained on and tested using peripheral blood samples. But the brain is an incredibly isolated, highly privileged immune environment.
SPEAKER_01It has its own walled garden.
SPEAKER_00Exactly. The epigenetic changes happening in the neurons, the astrocytes, and the microglia, which are the brain's immune cells, they do not easily cross the blood-brain barrier to show up in your peripheral bloodstream.
SPEAKER_01So the blood is telling a completely different story than the cerebrospinal fluid.
SPEAKER_00Precisely. To truly track cognitive aging, we would need epigenetic clocks trained on cerebrospinal fluid, which requires a spinal tap. And that is not exactly a scalable routine diagnostic test.
SPEAKER_01Yeah, I'm not doing that at my annual physical.
SPEAKER_00No one is. This is why the field is desperately shifting toward precision gerontology. The WIM study is a massive wake-up call that we have to stop optimizing purely for lifespan and start developing specific targeted biomarkers for health span, particularly brain health.
SPEAKER_01Okay, so if systemic epigenetic clocks can't predict cognitive decline, what is actually driving it? We know something has to be pulling the strings behind the blood-brain barrier.
APOE As A Tunable Risk Dial
SPEAKER_01And when I was looking through the research on what actually dictates whether you lose your memory or not, one specific gene absolutely dominated the data. We have to talk about APOE.
SPEAKER_00Yes. Epolipoprotein E. If you want to understand the genetics of sporadic Alzheimer's disease and cognitive longevity, you must understand APOE. It is the architect of the brain's fate.
SPEAKER_01Right. So for you listening, let's lay this out. APOE is a gene, and it comes in three distinct flavors or isoforms, right? E2, E3, and E4.
SPEAKER_00Correct. You inherit one allele from each parent, giving you your specific genotype. The E3E3 combination is by far the most common in the population. It basically serves as the baseline for normal human cognitive aging. But the variants, E2 and E4, drastically alter your trajectory.
SPEAKER_01And E4 is the bad one.
SPEAKER_00Bad is an understatement. Having just one copy of the E4 allele, say URE3E4 increases your risk of developing sporadic Alzheimer's disease by approximately fourfold compared to the baseline. Wow. And if you happen to inherit two copies, an E4, E4 genotype, your lifetime risk increases by up to twelvefold.
SPEAKER_01Twelvefold. I mean, that feels like a genetic death sentence. That's practically a guarantee you're going to get Alzheimer's. Conversely, though, the E2 allele is the golden ticket, right?
SPEAKER_00It is highly neuroprotective. Individuals with the E2 allele have a significantly reduced risk of Alzheimer's and are heavily overrepresented in populations of centenarians who maintain their cognitive faculties.
SPEAKER_01Okay, but why? What is E2 already? For physically doing inside the brain that E2 isn't. Because honestly, for years, the only thing I ever heard about Alzheimer's was amyloid plaques. The amyloid hypothesis, it was all about these sticky plaques just gunking up the brain.
SPEAKER_00It's true that the APOE protein is responsible for binding and clearing amyloid beta from the brain. And the E4 isoform binds it differently, leading to faster aggregation and slower clearance of those plaques. But recent research shows that the devastation of E4 goes far beyond just amyloid. It is vastly more insidious.
SPEAKER_01Okay, bring it down. What else is it doing?
SPEAKER_00The presence of the E4 allele actively drives tau-mediated neurodegeneration, the tangles inside the neurons that actually kill the cell. Furthermore, it causes severe microglial dysfunction.
SPEAKER_01Microelia, those are the immune genitors of the brain, right? They sweep up the dead cells and debris.
SPEAKER_00Exactly. But in the presence of E4, these janitors become erratic and highly inflammatory. It also causes astrocyte reactivity, essentially bathing the brain tissue in a constant low-grade inflammatory state. And perhaps most structurally damaging, the E4 allele leads to the physical breakdown of the blood-brain barrier itself.
SPEAKER_01Wait, the wall protecting the brain from systemic toxins just starts to leak?
SPEAKER_00Yes. The tight junctions fail. So note now peripheral inflammation and toxins can flood directly into the brain tissue, significantly accelerating the decline.
SPEAKER_01Okay, that is incredibly bleak. If you are listening to this and you know you have the APOE E4 gene, that sounds terrifying. It sounds like absolute genetic fate. Like you just drew the short straw and you just have to wait for your brain to leak and catch fire. But this is a deep dive on epigenetics, the software layer. So, how much of this is actually fate?
SPEAKER_00This is where the narrative shifts from despair to incredible empowerment, because APOE is absolutely not just genetic fate. The expression of the APO being, how loud it is shouting its instructions into your brain, is heavily, heavily controlled by epigenetics.
SPEAKER_01Okay, bring us back to the molecular padlocks, the methyl groups.
SPEAKER_00Remember the CPG islands we discussed? The dense clusters of cytosine and guanine where methylation occurs? Well, the regulatory region of the APOE gene is incredibly dense with these CPG sites. And here is the most fascinating biological quirk. The sequence difference that creates the dangerous E4 allele actually introduces more CPG sites into the gene compared to E2 or E3.
SPEAKER_01Wait, hold on. Let me make sure I'm visualizing this correctly. The E4 allele, the dangerous one, has more physical spots for methylation to occur.
SPEAKER_00Exactly. The E4 allele has the greatest number of CPG sites. The protective E2 allele has the least.
SPEAKER_01Okay. So if CPG sites are basically the volume dials for a gene, the E2 allele is like a tiny little radio without much of a volume knob. It just quietly plays its protective tune in the background. But the E4 allele has this massive, highly sensitive, multi-channel volume dial built right into it.
SPEAKER_00That is an absolutely brilliant metaphor, yes. Because it has so many CPG sites, the E4 allele is uniquely susceptible to epigenetic regulation. Its expression can be cranked all the way up to a 10, flooding the brain with inflammation, or it can be heavily muted, dialed down to a one or a two.
SPEAKER_01And who turns the dial?
SPEAKER_00You do. Your environment, your lifestyle choices. This is why we see such massive clinical discordance, even among people with the highest risk, the E4E4 carriers. You will see one E4E4 individual develop severe Alzheimer's at 65. You will see another E4E4 individual remains cognitively sharp until 85 or 90.
SPEAKER_01They have the exact same hardware. What explains a 20-year difference in brain survival?
SPEAKER_00Epigenetic modifiers turning that massive volume dial. Environmental stimuli influence DNA methylation gradually over time. Diet is a profound modifier. Maintaining healthy lipid profiles and a high intake of polyunsaturated fatty acids directly alters the methylation patterns on the APOE promoter, turning the volume down on E4.
SPEAKER_01What about exercise?
SPEAKER_00Physical exercise physically alters the metabolic response of the prefrontal cortex and hippocampus. It induces the expression of enzymes that add protective methyl groups to the APOE gene, silencing the toxic downstream effects.
SPEAKER_01That is so profoundly empowering, completely reframes genetics. It's not, you know, you have the bad gene, game over. It's you have a highly sensitive gene, so you need to manage your software better than anyone else. Your lifestyle choices are literally physically reaching into your brain and turning the volume down on Alzheimer's.
SPEAKER_00Exactly. And beyond lifestyle, the scientific community is actively trying to develop therapies that manipulate this software. We're discovering entirely new layers of epigenetic control, like microRNAs.
SPEAKER_01Right. I read about this in the notes. Mir 650, what is a microRNA?
SPEAKER_00It's a tiny non-coding strand of RNA. It doesn't build a protein. Instead, it acts like an interceptor missile. The research showed that Mir 650 specifically targets the messenger RNA of the APOE gene and degrades it before it can build the APOV protein. It essentially gags the gene.
SPEAKER_01So if we could figure out a way to deliver or boost MIR-650 in the brain, we could theoretically just hit the mute button on the APOE E4 gene altogether.
SPEAKER_00In vitro, it significantly reduces APOE expression. Translating that into a safe human therapy that crosses the blood-brain barrier is immensely complex. But the proof of concept is there. We can intervene epigenetically.
SPEAKER_01And speaking of intervening, there was also mention of a literal gene therapy in the pipeline, LEX1001.
SPEAKER_00Yes, LEX1001 is a fascinating approach. It uses an adeno-associated viral vector, a hollowed out virus that can't make you sick but is excellent at sneaking into cells. They use this viral vector to deliver the protective APOE E2 allele directly into the central nervous system of patients who have the E4 genotype.
SPEAKER_01Dude, they are literally using a virus as an armored transport truck to drop the golden ticket E2 gene into the brain to fight the bad E4 gene. That is sci-fi level medicine.
SPEAKER_00It is the cutting edge of neurogenetics, attempting to artificially change the ratio of ApoE isoforms in the brain to halt neurodegeneration.
SPEAKER_01Okay, so we have viral gene therapy on the horizon. We have lifestyle choices turning the epigenetic volume dials. But let's dig into the how of that lifestyle piece. Because if my diet and my exercise dictate my APOE expression, how does the cell actually know? How does a neuron translate the fact that I skipped breakfast into a molecular signal that says turn down APOE and start repairing the DNA? What is the physical messenger?
SPEAKER_00To answer that, we really had to look at the master regulator of cellular stress.
FOXO3 And The Fasting Signal
SPEAKER_00We had to look at the longevity switch. It is time to talk about FOXO3.
SPEAKER_01FOXO3. Okay, I know a bit about the longevity pathways. You hear about MTR, you hear about autophagy, but FOXO3 seems to be the absolute grandmaster of the cell's repair systems.
SPEAKER_00If APOE is the architect of the brain's fate, FOXO3 is the master architect of cellular survival across the entire body. It is a transcription factor.
SPEAKER_01Meaning its job is to go into the nucleus, bind to the DNA, and turn genes on.
SPEAKER_00Exactly. The genes it turns on are incredible. When FOC XO3 enters the nucleus, it activates a massive battery of survival mechanisms, triggers cell cycle arrest, literally telling a damaged cell to stop dividing before it becomes cancerous. Wow. It upregulates DNA repair enzymes to fix mutations. It activates antioxidant defenses to clear out free radicals. And if the cell is too damaged to be saved, FOCXO3 triggers apoptosis, programs cell death for the greater good of the organism.
SPEAKER_01It is the ultimate triage medic. It assesses the damage and dictates survival. But a medic that powerful can't just be running around the cell turning things on and off all the time, right?
SPEAKER_00No. That would be chaotic. If FOXO3 is active all the time, the cell can never grow or divide. So FOCXO3 is kept under extraordinarily tight lock and key. It is heavily regulated by post-translational modifications.
SPEAKER_01Because software patches again.
SPEAKER_00Yes. And what is most fascinating in the recent research is a literal physical molecular turf war that happens on a single specific amino acid on the FOXO3 protein. We are looking at lysine 271.
SPEAKER_01Okay, I was looking at the proteomics data here, and this part is incredible. Set the scene for us. What is happening at lysine 271?
SPEAKER_00We have two major enzymatic players competing for control. The first is CERT1. Now, Cert 1 is a very famous anti-aging protein. It belongs to a family called CERTUINS. It is a decetylus, meaning it removes acetyl groups. For years we knew that during times of cellular stress, CERT1 removes an acetyl group from FOLCOXO3, specifically at lysine 271. This modification helps activate FOXO3.
SPEAKER_01Right, and CERT1 is heavily dependent on NAD plus IR, right, which connects it to energy metabolism. But then a new player enters the arena, SET 9.
SPEAKER_00Exactly. SET 9 is a methyltransferase. Its entire biological purpose is to add methyl groups. And it wants to methylate FOXO3. And where does it want to put that methyl group?
SPEAKER_01The exact same spot. Lysine 271. They are literally fighting over the exact same molecular parking spot.
SPEAKER_00They are competing directly. Because of steric hindrance physical crowding, they cannot both modify lysine 271 at the same time. It is mutually exclusive. If set 9 slaps a methyl group on that lysine, CERT 1 is physically blocked from interacting with it.
SPEAKER_01Okay, so if set 9 wins the fight and it methylates lysine 271, what does that actually physically do to the FOXO3 protein?
SPEAKER_00This is one of the most brilliant paradoxical pieces of biological engineering I have ever seen. When set 9 methylates FOCOX3, it actually causes a conformational change that decreases the physical stability of the protein. The half-life of FOC XO3 drops significantly. It is recognized by degradation machinery and destroyed much faster by the cell.
SPEAKER_01Yeah, wait, it gets destroyed faster. That sounds like a terrible thing. If FOXO3 is the medic and Set9 destroys the medic, how does the cell repair itself?
SPEAKER_00You would absolutely think it was a negative outcome. But here's the paradox. While the methylation makes the protein physically unstable and short-lived, it simultaneously massively increases its transcriptional activity.
SPEAKER_01I'm sorry, what it is physically falling apart, but it's working harder.
SPEAKER_00Think of it like a biological overdrive gear or a supernova. The methylation by set 9 turns FOXO3 into a highly active, highly concentrated, but very short-lived burst of stress response. It enters the nucleus, binds to the DNA, turns on the repair genes with furious efficiency, and then, because it is unstable, it gets degraded quickly.
SPEAKER_01Oh, because if it didn't get degraded, the cell would be permanently stuck in triage mode and could never go back to growing.
SPEAKER_00Exactly. It prevents pathological permanent cell cycle arrest. It is an exquisite fine-tuning dial. It allows for a massive, immediate response to stress, followed by a rapid return to normal cellular function once the damage is cleared.
SPEAKER_01That is just the sheer mechanical elegance of that is breathtaking. So the ultimate question for the listener right now is how do we manually reach into our cells and trigger that supernova? How do we flip the FOXO3 switch and tell it to start repairing our DNA?
SPEAKER_00The most robust, reliable, and evolutionarily conserved way to activate FOXO3 is through dietary restriction. Or as it's more commonly practiced, fasting.
SPEAKER_01Right. We all know fasting triggers repair pathways. Everyone in the longevity space talks about MTOR and autophagy when you fast. But what blew my mind in these sources was the exact molecular cascade, the physical messenger. Walk us through the actual pathway. I skipped breakfast. What happens in the blood?
SPEAKER_00When you restrict nutrients, specifically protein and glucose, your body senses the deprivation. Consequently, the circulating levels of a hormone called IGF1 insulin-like growth factor, one drop significantly in your bloodstream.
SPEAKER_01Okay, IgF-1 drops. How does the cell sense that?
SPEAKER_00Your cells have IgF-1 receptors on their surface. When those receptors stop receiving the IGF-1 signal, it causes a cascading shutdown of a major signaling highway inside the cell called the ACTPKB pathway.
SPEAKER_01ACT. That's a kinase, right? Meaning its job is to phosphorylate things, to slap phosphate groups onto other proteins.
SPEAKER_00Aaron Powell Correct. When you are well fed and IgF1 is high, ACT is highly active. And what ACT does is aggressively phosphorylate FOXO3.
SPEAKER_01Aaron Powell And what does adding a phosphate group to FOXO3 do?
SPEAKER_00Aaron Powell It creates a binding site for a family of chaperone proteins called 1433 proteins. These proteins physically grab the phosphorylated FOXO3 and drag it out of the nucleus, trapping it in the cytoplasm. It literally locks the medic out of the hospital.
SPEAKER_01Aaron Powell Because if you're eating a massive meal, the cell is in growth mode. It wants to divide and build tissue. It absolutely does not want FXSO3 inside the nucleus ceiling. Stop growing, let's look for DNA mutations.
SPEAKER_00Aaron Powell Precisely. Growth and repair are mutually exclusive biological states. You cannot do both optimally at the same time. But when you fast turns off.
SPEAKER_01The phosphorylation stops.
SPEAKER_00The lock breaks. The 1433 proteins release FOXO3, and FOXO3 rushes back into the nucleus, triggers the CERT1 and SET 9 dynamic, and initiates a massive systemic cellular repair and cleanup process.
SPEAKER_01I mean, the fact that the feeling of hunger, your stomach growling, is fundamentally the exact same biological signal as your DNA being scrubbed clean and your epigenetic software being optimized. You are literally leveraging an ancient evolutionary survival mechanism.
SPEAKER_00You are. In times of famine, a species cannot afford to expend energy on reproduction or tissue growth. The organism must hunker down, repair existing cellular damage, and survive until the food supply returns. That deep evolutionary survival pathway is the anti-aging pathway.
SPEAKER_01It makes so much sense. But okay, listen, let me be the voice of the average person here. Fasting is hard, people like foods, skipping meals sucks. So naturally, the entire biomedical industry is asking the same question. Can we just take a pill to do this? Can we get the FOXO3 repair and the APOE muting without the hunger?
SPEAKER_00Ah, the holy grail. The quest for the fasting pill in a bottle. This is the cutting edge of longevity pharmacology testing existing drugs against these biological classes to see if we can chemically reverse epigenetic
Metformin Rapamycin And The Reality Check
SPEAKER_00age.
SPEAKER_01Right. And everyone in the longevity space is constantly debating the big three: metformin, caloric restriction, and rapamycin. So let's talk about the pills. What does metformin actually do?
SPEAKER_00Metformin is primarily a type 2 diabetes drug, but it has massive longevity implications. Mechanistically, it inhibits complex eye in the mitochondria, which slightly restricts cellular energy production. This drop in energy activates an energy sensing enzyme called AMPK.
SPEAKER_01Which basically tricks the cell into thinking it's starving, even if it isn't.
SPEAKER_00Essentially, yes. Activating AMPK triggers downstream pathways that mimic many of the effects of nutrient deprivation, leading to improved metabolic markers and potentially delayed epigenetic aging. But the drug that generates the most excitement right now is undoubtedly rapamycin.
SPEAKER_01Rapamycin, yes, the crown jewel. It physically inhibits MTOR, right, which is the mammalian target of rapamycin. And inhibiting MTOR basically forces the cell to stop growing and start cleaning up, very similar to Evoxo3 activation. People are taking this off label right now. I know people taking it. They treat it like the immortality pill.
SPEAKER_00And here's where we must introduce a very dry, very sobering scientific reality check. Because the translation to pharmacology from bench to bedside is littered with failures. Rapamycin is fundamentally an immunosuppressant. Now, the excitement is warranted based on early data. In mice, when researchers administered rapamycin for 22 months, it significantly decreased their DNA methylation epigenetic age compared to the control group. It was a staggering success.
SPEAKER_01A massive success in mice, but I can hear the butt in your voice. What happened next?
SPEAKER_00The researchers took the next logical step. They moved from short-lived rodents to long-lived primates. They tested rapamycin on a cohort of common marmosets.
SPEAKER_01Marmosets, which are evolutionarily much closer to us. Their biology, their metabolism is vastly more similar to a human than a mouse's.
SPEAKER_00Exactly. They treated these marmosets with daily rapamycin for over two years, a very robust longitudinal study. As a result, rumroll. Rapamycin administration did not significantly change their DNA methylation epigenetic age.
SPEAKER_01Oh wow. Nothing. No biological time travel for the monkeys.
SPEAKER_00No significant epigenetic age reversal whatsoever.
SPEAKER_01Why? If it works so perfectly in a mouse, why does it completely fail to change the epigenetic clock in a primate?
SPEAKER_00Because of the profound complexity of primate metabolic compensation. Mice are short-lived, fast metabolism organisms. Their biological pathways are essentially a straight line. You block MTOR, the system shifts immediately to repair. But primates, humans included, are designed for extreme longevity already. We have highly complex, redundant feedback loops.
SPEAKER_01So they fight back.
SPEAKER_00Yes. When you artificially suppress MTOR in a primate with a drug, the body senses the chemical blockage and simply reroutes. It upregulates compensatory pathways to maintain its biological equilibrium.
SPEAKER_01So the primate body basically says, nice try with the rapamycin, but I have a backup system and a backup for the backup, and we're going to keep aging normally.
SPEAKER_00Precisely. It is a vital reminder of the fundamental rule of longevity science. Mice are not tiny humans. And mice are certainly not tiny marmosets. We are making unbelievable strides in understanding the mechanisms of aging. We understand FOC XO3, we understand APOE, we understand the methylation clocks, but we're absolutely not at the immortality pill in a bottle stage. Biology and long-lived primates is stubbornly resilient.
SPEAKER_01Honestly, that is a bummer for the people popping off label pills, but it is such an important point. It means I can't just eat donuts, avoid the gym, pop a lapomycin, and expect my grimmage to say I'm 20. The lifestyle stuff, the fasting, the exercise, the sleep, it still holds the crown because it triggers the entire systemic symphony of pathways, not just one isolated protein.
SPEAKER_00It does. The most effective scientifically validated epigenetic modifiers we currently have access to are behavioral and dietary. You have to earn the epigenetic reversal.
SPEAKER_01Okay.
Closing Thoughts On Rewriting Time
SPEAKER_01Let's pull all of this together because we have covered an insane amount of molecular ground today. Let's summarize the journey. We started with the physical reality of the epigenome, the methylation rust on our DNA.
SPEAKER_00The steric hindrance of methyl groups silencing our genes, and the realization that this process is so mathematically predictable that we can build epigenetic clocks like grimmage to read our biological decay, proving that chronological age is comforting, but biological age is the actual receipt.
SPEAKER_01Then we met the superagers, the centenarians who are biologically decades younger than their birth certificates, who prove that epigenetic drift, the chaotic noise of aging, isn't inevitable for everyone. And we saw that we can actually pick the padlocks off the genes, like curing blindness in mice by simply turning the ELVL2 gene back on.
SPEAKER_00But we also confronted the cognitive blind spot through the WIM study. The terrifying reality that our systemic blood clocks can predict when your heart will fail, but are utterly blind to the epigenetic neurodegeneration happening behind the blood brain barrier.
SPEAKER_01Which led us to APOE, the architect of that brain decline. And the realization that even if you carry the massive risk of the E4 allele, the fact that it has so many CPG sites makes it a highly sensitive volume dial. Your lifestyle is the hand turning that dial down.
SPEAKER_00And finally, we explored the mechanical elegance of FAXO3, the molecular turf war at lysine 271, and the beautiful realization that the simple act of experiencing hunger drops your IGF-1, breaks the ACT lock, and sends a burst of repair proteins into your nucleus to scrub your DNA clean.
SPEAKER_01It fundamentally changes how you look at yourself in the mirror. You are not a static machine with a fixed odometer. You are a dynamic, highly responsive biological software system.
SPEAKER_00Which leaves us with a highly provocative final thought to consider. We have spent all of human history, our art, our philosophy, our economic systems, assuming that aging and decay are inevitable, untreatable conditions. Life has always been a one-way arrow of time. Right. But if aging is actually just a biochemical software program governed by reversible methylation, and we are actively learning how to rewrite that code, what happens to human psychology? What happens to ambition, to relationships, to the structure of society as a whole when running out of time is no longer the default foundational assumption of human existence.
SPEAKER_01Yeah.
SPEAKER_00What do you do with your life when the biological odometer is suddenly meaningless and your cellular Carfax report says you have the capacity to drive for another century?
SPEAKER_01Dude, I I don't even know how to process that. That completely changes the stakes of everything. I am going to be thinking about that all week. All right. That is our deep dive for today. Keep your biological software updated, embrace a little bit of hunger, stay curious, and we'll see you next time.